Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK Interaction of Valsartan, Amlodipine, and HCTZ in Hypertension
NCT00548067Phase 3Completed
- Sponsor
- Novartis
- Start
- Sep 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of valsartan, amlodipine and hydrochlorothiazide in hypertension (HTN) (4 arms), sponsored by Novartis. Primary endpoint: Potential drug interaction and effect on blood level of drugs at 17 days. Started Sep 2007; status: completed.
02
Drugs
valsartanamlodipinehydrochlorothiazide
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT00548067.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00548067.